Rates and Characteristics of Serious Adverse Events (SAEs) in 210 Patients with Idiopathic Pulmonary Fibrosis (IPF) Treated with Interferon-Gamma 1b (IFN-gamma 1b) in an Open-Label Study
| Autor: | David A. Zisman, Karen M. Starko, Williamson Z. Bradford |
|---|---|
| Rok vydání: | 2004 |
| Předmět: |
Pulmonary and Respiratory Medicine
medicine.medical_specialty Interferon type II business.industry Critical Care and Intensive Care Medicine medicine.disease Gastroenterology Idiopathic pulmonary fibrosis Open label study Internal medicine medicine Cardiology IFN-gamma 1b INTERFERON GAMMA-1B Cardiology and Cardiovascular Medicine Adverse effect business medicine.drug |
| Zdroj: | Chest. 126:772S |
| ISSN: | 0012-3692 |
| DOI: | 10.1378/chest.126.4_meetingabstracts.772s |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|